Randomised Controlled Trial of the Diabetes Self-Management ‘Glucose Buddy’ Smartphone Application.

Not Applicable

Completed

• Conditions: Type 1 Diabetes; Effect of a diabetes self-management smartphone application; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12612000132842
• Lead Sponsor: Central Queensland University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-01-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

Diagnosed with Type 1 Diabetes
-Duration of disease > 6 months
-Treated with multiple daily injections (MDI) or continuous subcutaneous insulin injections (Insulin Pump)
-Inadequate glycemic control (HbA1c > 8%)
-Own an iPhone and not currently using an iPhone application to self-monitor diabetes
-Consent from patient and patient’s general practitioner to participate

Exclusion Criteria

-Pregnant patients with Type 1 Diabetes
-Early indicators of diabetes related complications: retinopathy, neuropathy, nephropathy and heart-disease

General practitioner or endocrinologist of patient had to provide consent for their participation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified